logo
ResearchBunny Logo
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants

Medicine and Health

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants

W. Tai, S. Feng, et al.

This innovative study by Wanbo Tai and colleagues introduces a groundbreaking mRNA-based vaccine that effectively targets conserved regions of the SARS-CoV-2 virus. By focusing on T-cell responses and combining it with existing RBD-based vaccines, this research shows promising results against emerging variants, underscoring the importance of robust immune response for effective COVID-19 vaccination.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny